Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Migraine

Free Subscription 08.12.2025 1 Ann Pharmacother 3 Cephalalgia 1 Curr Opin Neurol 3 Headache 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Pharmacother

1. TERPENING CM, Wietholter JP
   Dihydroergotamine Intranasal Powder for Acute Migraine Treatment.
   Ann Pharmacother. 2025 Dec 4:10600280251388440. doi: 10.1177/10600280251388440.
   PubMed         Abstract available
   
   

   
   Cephalalgia

2. GRECO R, Bighiani F, Demartini C, Zanaboni A, et al
   miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells.
   Cephalalgia. 2025;45:3331024251386769.
   PubMed         Abstract available
   
   
3. IANNONE LF, Romozzi M, Russo A, Finkelstein I, et al
   Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).
   Cephalalgia. 2025;45:3331024251398011.
   PubMed         Abstract available
   
   
4. ATRASZKIEWICZ D, Unal E, Bassett P, Morell-Ducos F, et al
   Greater occipital nerve block for the treatment of migraine: An umbrella review, systematic review, and meta-analysis.
   Cephalalgia. 2025;45:3331024251398390.
   PubMed         Abstract available
   
   

   
   Curr Opin Neurol

5. VILLAR-MARTINEZ MD, Abdalla A, Goadsby PJ
   Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches.
   Curr Opin Neurol. 2025 Nov 28. doi: 10.1097/WCO.0000000000001447.
   PubMed         Abstract available
   
   

   
   Headache

6. GUNASEKERA L, Cheng S, Foster E, Sivathamboo S, et al
   A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in Australia.
   Headache. 2025 Dec 2. doi: 10.1111/head.70015.
   PubMed         Abstract available
   
   
7. ROBBLEE J, Minen MT, Friedman BW, Cortel-LeBlanc MA, et al
   2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies.
   Headache. 2025 Dec 1. doi: 10.1111/head.70016.
   PubMed         Abstract available
   
   
8. MUNOZ-VENDRELL A, Campoy-Diaz S, Diaz-Corta P, Termens L, et al
   False nonresponders to anti-calcitonin gene-related peptide monoclonal antibodies: A real-world analysis beyond migraine frequency reduction.
   Headache. 2025 Nov 28. doi: 10.1111/head.70012.
   PubMed         Abstract available
   
   

   
   PLoS One

9. YAN J, Wang X, Ding B, Zhang M, et al
   Household fuel use and migraine among Chinese adults aged 45 years and older: The modifying effects of sleep.
   PLoS One. 2025;20:e0335407.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.